TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›DDS›Financials
Annual statements · SEC XBRL · FY2017 – FY2026

DILLARD'S, INC. (DDS) financials

Income statement

DILLARD'S, INC. (DDS) income statement, annual, from SEC filings
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue$6.42B$6.42B$6.50B$6.34B$4.43B$6.49B$6.87B$6.75B$6.48B$6.47B
Revenue growth—0.1%1.3%-2.5%-30.1%46.5%5.8%-1.7%-4.0%-0.1%
Gross profit$2.09B$2.06B$2.06B$1.97B$1.23B$2.75B$2.89B$2.72B$2.56B$2.56B
Gross margin32.6%32.1%31.7%31.0%27.8%42.3%42.0%40.3%39.5%39.5%
Net income$169M$221M$170M$111M-$71.7M$862M$892M$739M$593M$570M
Net margin2.6%3.4%2.6%1.8%-1.6%13.3%13.0%10.9%9.2%8.8%
EPS (diluted)$4.93$7.51$6.23$4.38-$3.16$41.88$50.81$44.73$36.82$36.42

Cash flow

DILLARD'S, INC. (DDS) cash flow, annual, from SEC filings
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow$512M$274M$367M$365M$253M$1.28B$948M$884M$714M$717M
Capital expenditures$105M$130M$137M$103M$60.5M$104M$120M$133M$105M$93.4M
Free cash flow$407M$144M$230M$262M$192M$1.18B$828M$751M$610M$624M
Share buybacks$240M$223M$130M$131M$103M$545M$453M$281M$121M$108M
Dividends paid$9.79M$9.42M$11.1M$11.5M$14.0M$305M$271M$339M$414M$485M

Balance sheet

DILLARD'S, INC. (DDS) balance sheet, annual, from SEC filings
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash & equivalents$347M$187M$124M$277M$360M$717M$650M$808M$718M$861M
Total assets$3.90B$3.68B$3.43B$3.43B$3.09B$3.25B$3.33B$3.45B$3.53B$3.51B
Long-term debt$526M$365M$366M$366M——————
Shareholders' equity$1.72B$1.71B$1.68B$1.62B$1.44B$1.45B$1.60B$1.70B$1.80B$1.78B
Retained earnings$4.15B$4.37B$4.46B$4.56B$4.47B$5.03B$5.65B$6.05B$6.23B$6.31B
Shares (wtd avg diluted)34.3M29.5M27.3M25.4M22.7B20.6B17.5B16.5B16.1B15.7B

Every figure is extracted from DILLARD'S, INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is DILLARD'S, INC.'s annual revenue?
DILLARD'S, INC. (DDS) reported $6.47B of revenue for fiscal year 2026 — down 0.1% from $6.48B in FY2025, per its annual report filed with the SEC.
Is DILLARD'S, INC. profitable?
Yes — DDS earned $570M of net income in FY2026, a 8.8% net margin, per SEC filings.
What is DILLARD'S, INC.'s free cash flow?
$624M in FY2026 (operating cash flow $717M minus $93.4M of capital expenditures), from the SEC cash-flow statement.
Does DDS pay a dividend?
Yes — DILLARD'S, INC. paid $485M in cash dividends during FY2026, per its SEC cash-flow statement.
Full DDS analysis — verdict, score & filings →Is DDS a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.